Course Information
12th Annual UCLA Liver Diseases Symposium

The Westin Pasadena
Pasadena, California
October 20, 2018
*Please note that the course syllabus will be available online only to registered attendees.
A password link will be sent prior to the course.

Download: [ PDF ]

Course Description

This symposium will serve as an educational forum for the Southern California physician community for the scientific exchange of information regarding the diagnosis and treatment, medical and surgical, of the most prevalent liver diseases.

Registration Information


To enroll click here.

By Mail

Send the completed enrollment form to:

David Geffen School of Medicine at UCLA
Office of Continuing Medical Education
12th Annual UCLA Liver Diseases Symposium
10920 Wilshire Blvd., Suite 1060
Los Angeles, CA 90024-6512

By Fax

Fax the enrollment form with charge card information and your authorizing signature to (310) 794-2624.

By Phone

Use your American Express, MasterCard, VISA, or Discover card. Call (310) 794-2620

Course Fees

  • $125 Physicians
  • $75 Allied Health Professionals
  • $25 Fellows and Residents (letter of verification from director required)


No refunds will be granted for this conference, due to the low enrollment fee. A full refund will be provided if for any reason the course must be cancelled or rescheduled.



Francisco Durazo, MD, FACP, FAASLD
Professor of Medicine and Surgery
Chief, Transplant Hepatology
Medical Director, Dumont-UCLA Liver Transplant Center


Myron Tong, PhD, MD, FAASLD
Professor of Medicine and Surgery
Director of Clinical Hepatology
Associate Director, UCLA Liver Cancer Center
Director of Asian Liver Center

Course Faculty

Simon Beaven, MD, PhD
Assistant Professor of Medicine
Director of Research, Center for Obesity and METabolic Health (COMET)
Division of Digestive Diseases and Pfleger Liver Institute

Ronald Busuttil, MD, PhD
William P. Longmire, Jr. Chair in Surgery
Distinguished Professor and Executive Chairman
Chief, Division of Liver and Pancreas Transplantation
Director, Dumont-UCLA Liver Transplant and Cancer Centers

Peter Butler, MD
Professor of Medicine
Director, Larry Hillblom Islet Research Center

Gina Choi, MD
Assistant Clinical Professor of Medicine and Surgery
Associate Director, Transplant Hepatology Fellowship Program
Pfleger Liver Institute

Erik P. Dutson, MD, FACS
Clinical Professor of Surgery
Chief, Section of Minimally Invasive and Bariatric Surgery
Surgical Director, Center for Obesity and
METabolic Health (COMET)
Executive Medical Director, CASIT

Mohamed El Kabany, MD
Associate Clinical Professor
Division of Digestive Diseases
Pfleger Liver Institute

Antoinette S. Gomes, MD
Professor of Radiology and Medicine
Cardiovascular and Interventional Radiology

Steven Han, MD, AGAF, FAASLD
Professor of Medicine and Surgery
Program Director, Transplant Hepatology Fellowship
Director, Hepatology Clinical Research Center

Jonathan R. Hiatt, MD
Professor of Surgery
Vice Dean for Faculty

Zhaoping Li, MD, PhD
Professor of Medicine
Director, Center for Human Nutrition
Chief, Division of Clinical Nutrition

David Lu, MDCM
Professor of Radiology and Surgery
Director, CT and Cross Sectional Interventional Radiology
Director, Interventional Oncology

Professor of Medicine and Surgery
Assistant Professor of Nursing
Head, Outcomes Research in Hepatology
Dumont-UCLA Liver Transplant Center

Beshoy Yanny, MD
Clinical Instructor of Hepatology
UCLA Medical Center, Santa Monica

Program Agenda

Saturday, October 20, 2018

7:30 Registration and Continental Breakfast
8:30 Introduction
Jonathan R. Hiatt, MD
Session I: Chronic Hepatitis
Moderator: Steven Han, MD
8:40 Autoimmune and Cholestatic Liver Disease
Gina Choi, MD
9:00 Treatment and Epidemiology of HCV Infection, Present, and Future
Sammy Saab, MD, MPH
9:20 Management of Hepatitis B During Pregnancy
Myron Tong, PhD, MD
9:40 Questions and Answers
10:00 Break
Session II: Metabolic Syndrome
Moderator: Francisco Durazo, MD
10:15 Bariatric Surgery
Erik P. Dutson, MD
10:35 Nutrition
Zhaoping Li, MD, PhD
10:55 Cause and Consequences of Hepatic Insulin Resistance in Diabetes
Peter Butler, MD
11:15 The Natural History of NAFLD/NASH
Simon Beaven, MD, PhD
11:35 Questions and Answers
12:00 Lunch
Session III: Non-Invasive Assessment of Liver Fibrosis
Moderator: Mohamed El Kabany, MD
1:20 MR Elastography and Fat/Iron Quantitation
David Lu, MDCM
1:40 Does This Patient with Liver Disease Have Cirrhosis?
Beshoy Yanny, MD
2:00 Intestinal Microbiome and Liver Diseases
Francisco Durazo, MD
2:20 Questions and Answers
2:35 Break
Session IV: New Therapies for Tumors of the Liver
Moderator: David Lu, MDCM
2:50 Y-90 Infusion for Liver Tumors
Antoinette S. Gomes, MD
3:10 Hepatic Tumor Ablation: Status 2018
David Lu, MDCM
3:30 New Surgical Approaches to Liver Tumors
Ronald Busuttil, MD, PhD
4:00 Questions and Answers
4:15 Closing Remarks
Jonathan R. Hiatt, MD
4:30 Adjourn


At the conclusion of this program, participants will be able to:

  • Discuss new epidemiology of patients with hepatitis C
  • Explain the medical options for patients with NASH and the metabolic syndrome
  • Describe treatment of ascites and hepatic encephalopathy
  • Implement treatment guidelines for hepatitis B during pregnancy
  • Order different tests for the non-invasive assessment of liver fibrosis
  • Identify tumors that are amenable to surgical treatment


The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credits TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.


The FDA has issued a concept paper which classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is "truly independent" and free of commercial influence. In addition to independence, the FDA requires that nonpromotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program's participants. In addition, Accreditation Council for Continuing Medical Education policy mandates that the provider adequately manages all identified potential conflicts of interest prior to the program. We at UCLA fully endorse the letter and spirit of these concepts.


Conference Location

The Westin Pasadena
191 North Los Robles Avenue
Pasadena, CA 91101
(626) 792-2727


  • $6 Self
  • $17 Valet